{"news_desk": "Business", "print_page": "2", "section_name": "Business Day", "subsection_name": null, "document_type": "article", "multimedia": [], "abstract": "Aetna completes agreement with pharmaceutical company Gilead Sciences that will allow it to offer new hepatitis C treatment at a discounted rate to its nearly 11 million commercial customers.", "type_of_material": "Brief", "word_count": "146", "lead_paragraph": "The third-largest U.S. health insurer said it would offer the drug as the preferred choice to its nearly 11 million commercial customers.", "pub_date": "2015-01-17T00:00:00Z", "_id": "54b9b8f138f0d83735b5a8a3", "byline": {"contributor": "", "original": "By REUTERS", "person": [], "organization": "REUTERS"}, "source": "The New York Times", "snippet": "The third-largest U.S. health insurer said it would offer the drug as the preferred choice to its nearly 11 million commercial customers.", "web_url": "http://www.nytimes.com/2015/01/17/business/aetna-and-gilead-reach-deal-on-hepatitis-c-drug.html", "slideshow_credits": null, "blog": [], "keywords": [{"rank": "1", "is_major": "Y", "value": "Aetna Inc", "name": "organizations"}, {"rank": "2", "is_major": "Y", "value": "Gilead Sciences Inc", "name": "organizations"}, {"rank": "3", "is_major": "Y", "value": "Hepatitis", "name": "subject"}, {"rank": "4", "is_major": "Y", "value": "Drugs (Pharmaceuticals)", "name": "subject"}], "headline": {"main": "Aetna and Gilead Reach Deal on Hepatitis C Drug", "content_kicker": "Business Briefing", "print_headline": "Aetna and Gilead Reach Deal on Hepatitis C Drug", "kicker": "Business Briefing"}}